CALCA and migraine disorder: The treatment effect has previously been tested in serum, and similar effects were shown, as the α-CGRP levels were lower three months after the first dose of treatment but the same could not be said for the β-CGRP levels, as no significant difference was observed, which again supports the need for the further investigation of the involvement of each of the CGRP isoforms in migraine [34].